CMMB Q2 2025 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena

CMMBChemomab Therapeutics Ltd.

$12M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$33,687

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.36

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$11M

Total Liabilities

$1M

Stockholders' Equity

$10M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$33,687	-$26,901	-25.2%
Operating Income	-$2M	-$4M	+40.0%
Net Income	-$2M	-$4M	+43.3%